Valeant Pharmaceuticals International Investor Relations Salary
The average Valeant Pharmaceuticals International Investor Relations earns an estimated $59,992 annually. Valeant Pharmaceuticals International's Investor Relations compensation is $21,939 less than the US average for a Investor Relations.
The Communications Department at Valeant Pharmaceuticals International earns $17,064 more on average than the Enterprise Risk Department.
Last updated 2 years ago.
- $59,992
- avg. base
Investor Relations Salaries at Valeant Pharmaceuticals International
Compensation at Valeant Pharmaceuticals International by Department
The Communications Department averages $17,064 more than the Enterprise Risk Department.
Investor Relations Compensation by Gender (All Companies)
The average female Investor Relations at companies similar size to Valeant Pharmaceuticals International reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.
How Investor Relations at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Investor Relations at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Investor Relations at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
